Huifang Wang | Neuroscience | Best Researcher Award

 Dr. Huifang Wang | Neuroscience | Best Researcher Award

Huifang Elizabeth Wang is a leading research engineer at INSERM U1106, Aix-Marseille University, France, specializing in computational neuroscience. Her career bridges robotics, brain modeling, and clinical neuroscience, with a primary focus on personalized brain simulations for neurological and psychiatric conditions, notably epilepsy. With over a decade of postdoctoral research across top French and Italian institutes, she has contributed to projects integrating physics-based modeling, large-scale neural dynamics, and effective connectivity. Her academic journey started in robotics and control theory in China and evolved into advanced brain modeling in Europe. She collaborates with renowned neuroscientists like Dr. Viktor Jirsa and has authored numerous high-impact publications in Science Translational Medicine, The Lancet Neurology, and NeuroImage. As PI and co-leader in several EU and national projects, she aims to bridge basic brain science with clinical translation. Wang’s work is pivotal in creating virtual brain twins to personalize epilepsy surgery and psychiatric interventions.

Profile

🎓 Education

Huifang Elizabeth Wang obtained her Ph.D. in Pattern Recognition and Intelligent Systems from Beijing University of Technology in 2008, focusing on optimization algorithms for robotic motion under Prof. Chen Yangzhou. She earned her M.S. from the same institution in 2003, researching advanced traffic control strategies. Her undergraduate degree (B.S.) in Electronic Engineering was awarded by Shandong Institute of Light Industry in 2000. Complementing her engineering foundation, she undertook a research visit at LAAS-CNRS in Toulouse in 2007, developing time-optimal trajectories for car-like robots. Currently, she is finalizing her HDR (Habilitation à Diriger des Recherches) at Aix-Marseille University (Nov 2024) under the supervision of Dr. Viktor Jirsa, with a thesis on “Virtual Brain Twins.” Her education spans multiple disciplines and institutions, combining engineering, neuroscience, and clinical modeling. This interdisciplinary background underpins her leadership in personalized neural modeling and translational neuroscience research.

🧪 Experience

Wang is a Research Engineer at INSERM U1106, Aix-Marseille University (2017–present), leading work on virtual brain twins for clinical use in epilepsy and psychiatry. Prior, she was a Postdoc at the Institut du Cerveau (ICM), Paris (2016–2017), studying human neuron behavior with Pr. Vincent Navarro. At École des Mines de Saint-Étienne (2016), she helped develop a physiological SEEG atlas. From 2012–2016, she worked at INSERM U1106 on brain connectivity under Drs. Bernard and Jirsa. Earlier, she researched robotic control and planning at the University of Pisa (2008–2010) in Prof. Antonio Bicchi’s group. Her expertise spans brain modeling, robotics, and neuroscience, with leadership in multi-institutional EU-funded projects. She has served as PI and co-leader in several major efforts like the Human Brain Project and EPINOV. Her interdisciplinary experience uniquely equips her to bridge theory, technology, and medicine in brain modeling applications.

🏅 Awards and Honors

Huifang Elizabeth Wang has earned prestigious research roles and leadership positions in major European and national initiatives. She is PI for the AMIDEX-funded HR-VEP project and WP4 leader in the Horizon RIA Virtual Brain Twin initiative (2024–2027). Her projects have been supported by the Human Brain Project, France 2030, and Horizon Europe. She served as co-task leader in HBP’s epilepsy-focused work packages and trial coordinator in EPINOV RHU, a national clinical modeling trial. Her work on brain modeling has been published in high-impact journals, underscoring her scientific excellence. She has collaborated with pioneers like Karl Friston and Viktor Jirsa, advancing the fields of functional connectivity and computational neuroscience. Additionally, she has been granted funding by institutions such as Fondation Recherche Médicale and Ligue Française contre l’Épilepsie, recognizing her contributions to translational neuroscience and computational modeling in clinical applications.

🔬 Research Focus

Wang’s research centers on developing personalized virtual brain models to understand and treat brain disorders such as epilepsy and psychiatric conditions. She specializes in large-scale neural modeling using neural mass and field models, enabling individual-specific simulations—a concept known as “virtual brain twins.” Her work integrates multimodal neuroimaging data (e.g., SEEG, MRI) with computational frameworks to predict surgical outcomes and guide interventions. As part of projects like VEP Atlas, EPINOV, and EBRAINS, she builds anatomical-functional atlases for clinical use. She also advances Bayesian techniques for parameter estimation in brain modeling. Her research bridges basic neuroscience with translational applications, using virtual brains to delineate epileptogenic zones and simulate drug-resistant epilepsy spread. In psychiatric disorders, her focus includes simulating and analyzing network dysfunction to support precision psychiatry. By blending machine learning, dynamical systems, and neuroinformatics, Wang’s work pioneers a new frontier in personalized medicine using brain simulations.

Conclusion

Dr. Huifang Elizabeth Wang is an interdisciplinary researcher transforming clinical neuroscience through virtual brain modeling, combining engineering precision with neuroscientific insight. Her pioneering work in virtual brain twins supports individualized diagnosis and treatment of epilepsy and psychiatric disorders, representing a significant advance in precision medicine. With extensive experience, numerous publications, and leadership in high-impact research projects, she bridges theory and practice. Her scientific vision and collaborative leadership continue to shape the future of computational neuroscience and neurotechnology for patient care worldwide.

Publications

Elsa Pittaras | Neuroscience | Women Researcher Award

Dr. Elsa Pittaras | Neuroscience | Women Researcher Award

Elsa Pittaras is a Basic Life Research Scientist at Stanford University, specializing in neuroscience, cognition, and sleep research. With expertise in molecular biology, neuroanatomy, pharmacology, and behavior, she has extensively studied decision-making processes in mice. Her research has contributed significantly to understanding sleep deprivation’s effects on cognition and memory in Down Syndrome and Alzheimer’s disease models. She has published multiple papers as both first and last author, showcasing her leadership in neuroscience. Elsa’s goal is to advance research on mood disorders, cognition, and neurochemistry, aspiring to become an independent researcher in the U.S. 🇺🇸🔬🧠

Profile

Education 🎓

Elsa Pittaras earned a B.S. in Physiology from the University of Caen (2010), an M.S. in Neuroscience from the University of Paris Sud and ENS Cachan (2012), and a Ph.D. in Neuroscience from Neuro-PSI and the Biomedical Research Unit of the French Army (2016). Her multidisciplinary foundation in biology, physics, chemistry, and mathematics from Châtelet, Douai (2009) laid the groundwork for her neuroscience expertise. Throughout her education, she focused on decision-making, sleep deprivation, and neurochemical mechanisms in cognition. 🧠📚🎓

Experience 👨‍🏫

Elsa Pittaras has been a Basic Life Research Scientist at Stanford University since 2022, focusing on cognitive enhancement in Down Syndrome and Alzheimer’s disease models. She was a Postdoctoral Fellow at Stanford (2017-2022), investigating sleep and circadian rhythms’ effects on memory. Previously, she conducted research at the Biomedical Research Unit of the French Army (2016-2017) and completed her Ph.D. at Neuro-PSI. Her career includes internships in neuroscience at Neuro-PSI (2011-2012) and clinical observations at CHU Caen (2010). 🏛️🧬🧪

Research Interests 🔬

Elsa’s research explores decision-making, memory, and sleep in neurodevelopmental disorders. She pioneered the Mouse Gambling Task, revealing individual decision-making strategies. Her Ph.D. identified neurochemical markers of decision-making behaviors and the effects of sleep deprivation. At Stanford, she investigates sleep’s impact on cognition in Down Syndrome and Alzheimer’s models, aiming to improve memory and sleep quality through pharmacological interventions. Her work bridges behavioral neuroscience with neurochemistry to enhance cognitive function. 🧠💡🛌

Awards & Recognitions 🏅

Elsa has received prestigious grants, including the Jerome Lejeune Research Grants (2019, 2020), the Fyssen Foundation Research Grant (2017), and travel awards for conferences such as T21RS (2021) and Advances in Sleep and Circadian Science (2019). She was also recognized by the French Society for Research and Sleep Medicine (2014) and received a European Neuroscience Federation travel award (2016). 🏅

Publications 

  • Selectively Blocking Small Conductance Ca2+-Activated K+ Channels Improves Cognition in Aged Mice.

  • Short-term γ-aminobutyric acid antagonist treatment improves long-term sleep quality, memory, and decision-making in a Down syndrome mouse model

  • Behavioral and Neuronal Characterizations, across Ages, of the TgSwDI Mouse Model of Alzheimer’s Disease.

  • Inter-individual differences in cognitive tasks: focusing on the shaping of decision-making strategies

  • Handling, task complexity, time-of-day, and sleep deprivation as dynamic modulators of recognition memory in mice

  • Enhancing sleep after training improves memory in down syndrome model mice

 

Marcelo Luis Berthier | Neuroscience| Best Researcher Award

Prof. Marcelo Luis Berthier | Neuroscience| Best Researcher Award

 

Unversidad de Málaga, Spain

Profile

Education

Marcelo Luis Berthier obtained his degree in Medicine (1972-1976) and completed residency training in Neurosurgery (1977-1980), later specializing in Neurology (1980). He served as a staff neurologist at the Institute of Neurological Research, FLENI, Buenos Aires, Argentina (1980-1989), before becoming a research fellow in the Department of Neurology at Clinic Hospital of Barcelona, Spain (1989-1990). From 1991 to 2000, he was a staff neurologist and physician in charge of the Behavioural Neurology Unit at the Clinic University Hospital of Malaga. He earned a PhD in Neuroscience (cum laude) from the University of Malaga and coordinated the Group of Behavioural Neurology and Dementia of the Spanish Neurological Society (2004-2006). In 2004, he founded and directed the Unit of Cognitive Neurology and Aphasia at the Centro de Investigaciones Médico-Sanitarias, University of Malaga, leading it until 2023. Additionally, he served as the director of the Consolidated Research Group on Cognitive Neuroscience: Aphasia and Related Disorders (UNCA, C-12) at the Instituto de Investigación Biomédica de Málaga (IBIMA – Plataforma BIONAND).

Work experience

Dr. Marcelo L. Berthier Torres has led and contributed to several groundbreaking research projects in cognitive neurology and aphasia. As a co-investigator, he participated in the Telerehabilitation in Aphasia project (2021-2023), which evaluated the effectiveness of telerehabilitation compared to face-to-face therapy and identified predictive biomarkers of response, funded by the Junta de Andalucía. He also served as the principal investigator for a study on the efficacy of combined treatment with donepezil, intensive rehabilitation, and transcranial direct current stimulation in chronic post-stroke aphasia (2016-2019), funded by the Instituto de Salud Carlos III. Additionally, he has contributed to the Proyectos de Generación de Conocimiento “Frontera”, an initiative under the FEDER Andalucía 2014-2020 program, which investigates brain biomarkers for individualized treatment approaches in chronic post-stroke aphasia

Areas of Research

Dr. Marcelo L. Berthier Torres has made significant contributions to the treatment of post-stroke aphasia and speech-language disorders. He conducted the first open-label and randomized, placebo-controlled, double-blind trials investigating the use of cognitive-enhancing drugs (donepezil and memantine) alone and in combination with standard aphasia therapy or intensive language-action therapy (ILAT) in chronic post-stroke aphasia. His pioneering studies stimulated international research on aphasia pharmacotherapy, leading to clinical translation. Today, donepezil and memantine, alone or combined with therapy, are widely used off-label for post-stroke aphasia and language disturbances associated with neurodegenerative disorders like Alzheimer’s disease and primary progressive aphasia.

Publication

  • Revisiting the boundaries of different altered accents profiles

    Cortex
    2025-03 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Ignacio Moreno-Torres; Jo Verhoeven; Guadalupe Dávila
  • Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System

    CNS Drugs
    2023-07 | Journal article
    CONTRIBUTORS: Guadalupe Dávila; María José Torres-Prioris; Diana López-Barroso; Marcelo L. Berthier
  • Pharmacotherapy for post-stroke aphasia: what are the options?

    Expert Opinion on Pharmacotherapy
    2023-07-24 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Guadalupe Dávila
  • Brain structural and functional correlates of the heterogenous progression of mixed transcortical aphasia

    Brain Structure and Function
    2023-05-31 | Journal article
    CONTRIBUTORS: Diana López-Barroso; José Paredes-Pacheco; María José Torres-Prioris; Guadalupe Dávila; Marcelo L. Berthier
  • Controlling the past, owning the present, and future: cholinergic modulation decreases semantic perseverations in a person with post-stroke aphasia

    Aphasiology
    2022-11-02 | Journal article
    CONTRIBUTORS: Marcelo L. Berthier; Daniel Santana-Moreno; Álvaro Beltrán-Corbellini; Juan C. Criado-Álamo; Lisa Edelkraut; Diana López-Barroso; Guadalupe Dávila; María José Torres-Prioris